The PMHNP is performing an initial history and physical examination on a new patient who has just transferred to his care from out of state. The patient has a complex psychiatric history including schizoaffective disorder, generalized anxiety disorder, prolonged grief reaction, and adjustment disorder. His medication list indicates that he has been taking clozapine 300 mg daily for 15 months. The PMHNP recognizes that: A. This dose is subtherapeutic and should be increased in increments of 25 mg daily to a goal dose of 600 mg/day B. The patient must be routinely monitored for absolute neutrophil count C. Lithium is contraindicated in patients taking clozapine D. Clozapine is absolutely contraindicated in patients < 18 years of age ---YouTube: https://www.youtube.com/watch?v=G8vWlcwj1BY&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=55

Ver todos los episodios